Gamma-Delta (γδ)T Cell Therapy (Shattuck Labs)

N/A

Report date: 2022/11/02 10:00:06

Base Information

Drug NameGamma-Delta (γδ)T Cell Therapy (Shattuck Labs)
Drug Alias Nameγδ TCR (Shattuck Labs)Gamma Delta (γδ)T Cell Therapy (Shattuck Labs)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShattuck Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesShattuck Labs Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A